Pilot Study of a Minimally Invasive Procedure Using Lipiodol to Treat Chronic Heel Pain from Plantar Fasciitis in Adults Age 25 to 80

What this Trial Is About

Researchers are evaluating if lateral plantar artery embolization using Lipiodol can safely and effectively treat chronic heel pain caused by plantar fasciitis in adults aged 25 to 80. This pilot study aims to determine whether this minimally invasive procedure can reduce pain over 12 months and assess the safety by monitoring serious medical problems or adverse events related to the device. Participants will undergo a procedure where a doctor inserts a small tube catheter to inject Lipiodol, a temporary blocking agent, into specific blood vessels in the foot. The procedure targets branches of the lateral plantar artery associated with increased blood vessel growth linked to chronic plantar fasciitis. The injection is guided by imaging and uses up to 5 mL of Lipiodol to reduce pain and inflammation. After the procedure, participants will receive a phone call the next day to check for early side effects. They will then take part in four telehealth follow-up visits at 1, 3, 6, and 12 months, during which they will complete pain surveys using the Visual Analog Scale VAS and report any changes in other treatments or medications. Researchers will monitor pain changes and safety outcomes throughout the year-long study.

Lateral Plantar Artery Embolization For Plantar Fasciitis